Rocket Lab (RKLB) Financials

$66.34 +2.08 (+3.24%)

As of 02:08 PM Eastern

Annual Income Statements for Rocket Lab

This table shows Rocket Lab's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-55	-117	-136	-183	-190
Consolidated Net Income / (Loss)	-55	-117	-136	-183	-190
Net Income / (Loss) Continuing Operations	-55	-117	-136	-183	-190
Total Pre-Tax Income	-55	-125	-133	-179	-189
Total Operating Income	-55	-102	-135	-178	-190
Total Gross Profit	-12	-1.89	19	51	116
Total Revenue	35	62	211	245	436
Operating Revenue	35	62	211	245	436
Total Cost of Revenue	47	64	192	193	320
Operating Cost of Revenue	47	64	192	193	320
Total Operating Expenses	43	100	154	229	306
Selling, General & Admin Expense	24	58	89	110	132
Research & Development Expense	19	42	65	119	174
Total Other Income / (Expense), net	0.41	-23	2.26	-1.00	0.39
Interest & Investment Income	0.22	-6.13	-7.80	-4.25	-3.95
Other Income / (Expense), net	0.19	-17	10	3.25	4.34
Income Tax Expense	0.47	-7.52	3.00	3.65	0.76
Basic Earnings per Share	($0.73)	($0.56)	($0.29)	($0.38)	($0.38)
Weighted Average Basic Shares Outstanding	75.41M	209.90M	466.21M	481.77M	495.93M
Diluted Earnings per Share	($0.73)	($0.56)	($0.29)	($0.38)	($0.38)
Weighted Average Diluted Shares Outstanding	75.41M	209.90M	466.21M	481.77M	495.93M
Weighted Average Basic & Diluted Shares Outstanding	75.41M	209.90M	477.65M	489.14M	453.55M

This table shows Rocket Lab's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	-33	-46	-46	-41	-50	-44	-42	-52	-52	-61	-66
Consolidated Net Income / (Loss)	-37	-46	-46	-41	-50	-44	-42	-52	-52	-61	-66
Net Income / (Loss) Continuing Operations	-33	-46	-46	-41	-50	-44	-42	-52	-52	-61	-66
Total Pre-Tax Income	-38	-45	-45	-39	-49	-44	-42	-51	-52	-61	-63
Total Operating Income	-37	-46	-45	-39	-48	-43	-43	-52	-52	-59	-60
Total Gross Profit	1.83	6.36	15	15	15	24	27	28	37	35	46
Total Revenue	52	55	62	68	60	93	106	105	132	123	144
Operating Revenue	52	55	62	68	60	93	106	105	132	123	144
Total Cost of Revenue	50	49	47	53	44	69	79	77	96	87	98
Operating Cost of Revenue	50	49	47	53	44	69	79	77	96	87	98
Total Operating Expenses	39	52	60	54	63	67	70	80	88	94	106
Selling, General & Admin Expense	24	28	29	27	26	29	31	32	40	39	40
Research & Development Expense	15	24	31	27	37	39	40	48	48	55	66
Total Other Income / (Expense), net	-1.00	0.93	0.03	-0.36	-1.60	-1.18	0.78	0.90	-0.12	-2.24	-3.84
Interest & Investment Income	-0.89	-0.69	-0.75	-1.41	-1.41	-0.90	-0.82	-0.45	-1.78	-2.59	-2.37
Other Income / (Expense), net	-0.10	1.61	0.78	1.06	-0.20	-0.28	1.61	1.36	1.66	0.35	-1.47
Income Tax Expense	-5.16	0.53	0.76	1.35	1.01	0.01	-0.86	0.94	0.68	-0.81	2.94
Basic Earnings per Share	($0.08)	($0.10)	($0.10)	($0.08)	($0.10)	($0.09)	($0.08)	($0.10)	($0.11)	($0.12)	($0.13)
Weighted Average Basic Shares Outstanding	466.21M	476.20M	479.74M	484.03M	481.77M	489.99M	494.19M	497.70M	495.93M	505.61M	515.09M
Diluted Earnings per Share	($0.08)	($0.10)	($0.10)	($0.08)	($0.10)	($0.09)	($0.08)	($0.10)	($0.11)	($0.12)	($0.13)
Weighted Average Diluted Shares Outstanding	466.21M	476.20M	479.74M	484.03M	481.77M	489.99M	494.19M	497.70M	495.93M	505.61M	515.09M
Weighted Average Basic & Diluted Shares Outstanding	477.65M	478.66M	483.33M	485.89M	489.14M	492.78M	496.64M	499.91M	453.55M	461.43M	479.36M

This table details how cash moves in and out of Rocket Lab's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-44	638	-446	-79	109
Net Cash From Operating Activities	-28	-72	-107	-99	-49
Net Cash From Continuing Operating Activities	-28	-72	-107	-99	-49
Net Income / (Loss) Continuing Operations	-55	-117	-136	-183	-190
Consolidated Net Income / (Loss)	-55	-117	-136	-183	-190
Depreciation Expense	9.34	11	30	30	34
Amortization Expense	0.00	1.55	1.43	-1.67	0.19
Non-Cash Adjustments To Reconcile Net Income	15	52	61	88	88
Changes in Operating Assets and Liabilities, net	3.05	-19	-63	-33	19
Net Cash From Investing Activities	-37	-92	-346	12	-98
Net Cash From Continuing Investing Activities	-37	-92	-346	12	-98
Purchase of Property, Plant & Equipment	-25	-26	-42	-55	-67
Acquisitions	-12	-66	-66	-19	0.00
Purchase of Investments	0.00	0.00	-260	-207	-162
Sale of Property, Plant & Equipment	-	-	0.00	3.66	13
Sale and/or Maturity of Investments	0.00	0.00	22	269	116
Other Investing Activities, net	-	0.00	0.00	20	2.14
Net Cash From Financing Activities	21	800	2.04	7.37	257
Net Cash From Continuing Financing Activities	21	800	2.04	7.37	257
Repayment of Debt	0.00	0.00	4.38	-104	-58
Repurchase of Common Equity	0.00	0.00	-31	-16	-35
Issuance of Debt	0.00	99	0.00	110	0.00
Issuance of Preferred Equity	21	-	0.00	0.00	355
Other Financing Activities, net	0.98	701	29	17	-4.74
Effect of Exchange Rate Changes	-	2.13	4.37	0.04	-0.60
Cash Interest Paid	0.00	3.99	11	16	16
Cash Income Taxes Paid	-0.30	1.84	2.67	0.77	0.27

This table details how cash moves in and out of Rocket Lab's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Change in Cash & Equivalents	-90	-34	-11	-56	22	203	-25	-48	-21	33	261
Net Cash From Operating Activities	-19	-25	-6.06	-25	-42	-2.59	-13	-31	-2.39	-54	-23
Net Cash From Continuing Operating Activities	-19	-25	-6.05	-25	-42	-2.59	-13	-31	-2.39	-54	-23
Net Income / (Loss) Continuing Operations	-37	-46	-46	-41	-50	-44	-42	-52	-52	-61	-66
Consolidated Net Income / (Loss)	-37	-46	-46	-41	-50	-44	-42	-52	-52	-61	-66
Depreciation Expense	8.36	7.03	6.75	7.79	8.17	8.31	8.11	8.10	9.14	8.71	8.76
Amortization Expense	-0.25	-0.44	-0.25	-0.55	-0.43	-0.20	0.05	0.15	0.19	0.27	0.32
Non-Cash Adjustments To Reconcile Net Income	36	12	12	20	44	14	10	-18	81	23	30
Changes in Operating Assets and Liabilities, net	-26	1.72	21	-12	-44	20	10	30	-40	-26	3.60
Net Cash From Investing Activities	-73	-11	-6.22	-32	61	-52	-11	-17	-18	-29	-7.42
Net Cash From Continuing Investing Activities	-73	-11	-6.22	-32	61	-52	-11	-17	-18	-29	-7.42
Purchase of Property, Plant & Equipment	-15	-13	-11	-21	-10	-19	-15	-11	-22	-29	-32
Purchase of Investments	-80	-76	-56	-75	-	-79	-34	-36	-13	-85	-44
Sale of Property, Plant & Equipment	-	-	-	-	-	0.00	-	-	-	0.02	0.13
Sale and/or Maturity of Investments	21	78	76	65	50	46	28	29	13	85	68
Net Cash From Financing Activities	0.47	2.06	1.95	0.86	2.51	259	-1.76	-0.44	0.18	116	291
Net Cash From Continuing Financing Activities	-0.42	2.06	1.95	0.86	2.51	259	-1.76	-0.44	0.18	116	291
Repayment of Debt	-	0.00	-	-	-104	-54	-3.59	-3.03	46	-3.17	-8.31
Repurchase of Common Equity	-2.86	-1.92	-5.05	-5.38	-3.37	-5.16	-4.32	-5.69	-20	-17	-24
Issuance of Debt	-3.15	1.20	1.32	1.26	106	0.51	2.16	1.43	-4.10	27	2.60
Issuance of Common Equity	-	-	-	-	-	0.00	-	-	-	91	296
Other Financing Activities, net	1.21	2.77	5.68	4.99	3.67	-37	3.98	6.84	-22	17	24
Effect of Exchange Rate Changes	-	0.13	-0.61	0.04	0.48	-0.52	0.38	0.90	-1.36	0.27	0.86
Cash Interest Paid	3.16	3.42	3.63	3.69	4.81	2.27	2.32	9.65	2.05	9.58	2.72
Cash Income Taxes Paid	0.15	0.32	0.07	0.19	0.20	0.03	0.38	0.08	-0.21	0.21	0.21

This table presents Rocket Lab's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	188	981	989	941	1,184
Total Current Assets	93	775	662	477	693
Cash & Equivalents	53	691	243	163	271
Short-Term Investments	-	0.00	229	82	148
Accounts Receivable	2.73	14	37	35	36
Inventories, net	26	48	92	108	119
Prepaid Expenses	9.41	19	52	67	55
Other Current Assets	2.05	2.49	9.45	22	63
Plant, Property, & Equipment, net	50	65	102	145	195
Total Noncurrent Assets	45	141	225	319	297
Long-Term Investments	-	0.00	9.19	79	61
Noncurrent Note & Lease Receivables	-	0.00	16	15	14
Goodwill	3.13	43	71	71	71
Intangible Assets	11	57	80	68	59
Noncurrent Deferred & Refundable Income Taxes	2.40	5.86	3.90	3.50	3.01
Other Noncurrent Operating Assets	28	34	46	82	89
Total Liabilities & Shareholders' Equity	188	981	989	941	1,184
Total Liabilities	80	282	316	387	802
Total Current Liabilities	48	96	163	223	340
Short-Term Debt	0.00	2.83	2.91	18	12
Accounts Payable	3.37	3.49	12	29	53
Accrued Expenses	6.57	11	8.72	5.59	19
Current Deferred Revenue	-	-	108	139	216
Current Employee Benefit Liabilities	4.58	8.27	8.63	16	21
Other Current Liabilities	34	71	22	15	18
Total Noncurrent Liabilities	31	186	153	163	462
Long-Term Debt	0.00	97	100	88	389
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.47	0.10	0.43	0.89
Other Noncurrent Operating Liabilities	31	88	53	75	72
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	108	698	673	555	382
Total Preferred & Common Equity	-167	698	673	555	382
Preferred Stock	275	-	0.00	0.00	0.00
Total Common Equity	-167	698	673	555	382
Common Stock	20	1,002	1,113	1,177	1,199
Retained Earnings	-188	-305	-441	-624	-814
Treasury Stock	-	-	-	-	0.00
Accumulated Other Comprehensive Income / (Loss)	1.06	1.31	1.14	1.54	-2.81

This table presents Rocket Lab's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025
Total Assets	1,001	991	981	950	1,182	1,189	1,153	1,255	1,553
Total Current Assets	699	635	560	506	726	752	695	725	1,006
Cash & Equivalents	333	208	197	141	366	341	292	303	564
Short-Term Investments	169	190	144	148	127	156	150	125	124
Accounts Receivable	58	51	25	23	31	50	22	39	62
Inventories, net	86	98	102	102	100	105	114	126	130
Prepaid Expenses	44	63	64	68	79	81	67	71	74
Other Current Assets	9.06	24	28	24	23	19	49	61	52
Plant, Property, & Equipment, net	94	96	120	136	148	156	171	214	250
Total Noncurrent Assets	208	260	301	308	308	281	287	316	297
Long-Term Investments	9.75	48	74	82	69	46	61	84	61
Noncurrent Note & Lease Receivables	16	15	15	15	15	15	15	14	14
Goodwill	60	71	71	71	71	71	71	71	71
Intangible Assets	83	76	73	70	67	64	62	56	54
Noncurrent Deferred & Refundable Income Taxes	3.24	3.50	3.64	3.28	3.35	1.57	1.42	3.77	2.10
Other Noncurrent Operating Assets	37	45	64	66	84	83	77	87	95
Total Liabilities & Shareholders' Equity	1,001	991	981	950	1,182	1,189	1,153	1,255	1,553
Total Liabilities	311	351	370	365	703	733	733	824	865
Total Current Liabilities	161	197	306	304	232	266	269	348	376
Short-Term Debt	2.89	2.93	104	105	11	11	12	20	17
Accounts Payable	13	23	26	25	26	26	42	70	71
Accrued Expenses	9.59	8.68	6.49	6.00	9.09	12	8.06	12	23
Current Deferred Revenue	113	126	135	134	151	184	167	207	223
Current Employee Benefit Liabilities	8.56	12	14	15	14	14	19	22	24
Other Current Liabilities	14	25	20	19	22	19	20	16	18
Total Noncurrent Liabilities	149	154	65	61	471	467	464	476	488
Long-Term Debt	99	101	0.00	0.00	53	50	47	404	400
Noncurrent Deferred & Payable Income Tax Liabilities	0.02	0.17	0.24	0.31	0.53	0.62	0.73	1.03	1.18
Other Noncurrent Operating Liabilities	50	53	64	61	417	416	416	71	87
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	700	640	611	586	479	455	420	431	688
Total Preferred & Common Equity	691	640	611	586	479	455	420	431	688
Preferred Stock	-	-	-	-	-	-	-	0.01	0.01
Total Common Equity	700	640	611	586	479	455	420	431	688
Common Stock	1,099	1,126	1,145	1,161	1,149	1,165	1,179	1,308	1,629
Retained Earnings	-404	-487	-532	-573	-668	-709	-761	-874	-941
Treasury Stock	-	-	-	-	-	-	-	0.00	0.00
Accumulated Other Comprehensive Income / (Loss)	4.36	0.57	-1.76	-2.38	-1.80	-0.78	2.31	-2.37	0.71

This table displays calculated financial ratios and metrics derived from Rocket Lab's official financial filings.

Metric	2020	2021	2022	2023	2024
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	77.01%	239.02%	15.92%	78.34%
EBITDA Growth	0.00%	-134.06%	11.80%	-56.34%	-3.42%
EBIT Growth	0.00%	-116.78%	-5.42%	-39.57%	-6.17%
NOPAT Growth	0.00%	-85.71%	-32.48%	-31.59%	-6.68%
Net Income Growth	0.00%	-113.29%	-15.87%	-34.30%	-4.17%
EPS Growth	0.00%	23.29%	48.21%	-31.03%	0.00%
Operating Cash Flow Growth	0.00%	-158.64%	-48.40%	7.20%	50.55%
Free Cash Flow Firm Growth	0.00%	0.00%	-128.34%	41.44%	38.73%
Invested Capital Growth	0.00%	94.04%	174.29%	13.79%	-9.41%
Revenue Q/Q Growth	0.00%	0.00%	13.01%	3.48%	19.90%
EBITDA Q/Q Growth	0.00%	0.00%	-53.72%	-8.21%	-0.14%
EBIT Q/Q Growth	0.00%	0.00%	-41.54%	-6.56%	-0.99%
NOPAT Q/Q Growth	0.00%	0.00%	-10.54%	-6.37%	-1.97%
Net Income Q/Q Growth	0.00%	0.00%	-42.29%	-7.85%	-0.98%
EPS Q/Q Growth	0.00%	0.00%	-1,066.67%	-5.56%	-2.70%
Operating Cash Flow Q/Q Growth	0.00%	-27.70%	2.71%	-30.78%	44.89%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	-5.24%	-147.00%
Invested Capital Q/Q Growth	0.00%	0.00%	5.19%	4.78%	1,308.69%
Profitability Metrics	-	-	-	-	-
Gross Margin	-33.61%	-3.04%	9.00%	21.02%	26.63%
EBITDA Margin	-129.19%	-170.82%	-44.44%	-59.93%	-34.76%
Operating Margin	-156.29%	-163.97%	-64.08%	-72.74%	-43.51%
EBIT Margin	-155.75%	-190.74%	-59.31%	-71.41%	-42.52%
Profit (Net Income) Margin	-156.44%	-188.51%	-64.43%	-74.64%	-43.60%
Tax Burden Percent	100.86%	93.98%	102.26%	102.04%	100.40%
Interest Burden Percent	99.59%	105.16%	106.23%	102.43%	102.13%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-69.36%	-87.61%	-46.99%	-39.47%	-41.51%
ROIC Less NNEP Spread (ROIC-NNEP)	-38.03%	-73.36%	-38.47%	-20.02%	-2.90%
Return on Net Nonoperating Assets (RNNOA)	18.55%	58.53%	27.17%	9.73%	0.92%
Return on Equity (ROE)	-50.81%	-29.09%	-19.82%	-29.74%	-40.59%
Cash Return on Invested Capital (CROIC)	0.00%	-151.58%	-140.13%	-52.37%	-31.63%
Operating Return on Assets (OROA)	-29.15%	-20.31%	-12.71%	-18.10%	-17.45%
Return on Assets (ROA)	-29.28%	-20.08%	-13.80%	-18.92%	-17.89%
Return on Common Equity (ROCE)	78.25%	-19.17%	-19.82%	-29.74%	-40.59%
Return on Equity Simple (ROE_SIMPLE)	32.99%	-16.80%	-20.19%	-32.92%	-49.73%
Net Operating Profit after Tax (NOPAT)	-38	-71	-95	-125	-133
NOPAT Margin	-109.40%	-114.78%	-44.86%	-50.92%	-30.46%
Net Nonoperating Expense Percent (NNEP)	-31.33%	-14.26%	-8.53%	-19.45%	-38.61%
Return On Investment Capital (ROIC_SIMPLE)	-35.53%	-8.95%	-12.19%	-18.87%	-16.95%
Cost of Revenue to Revenue	133.61%	103.04%	91.00%	78.98%	73.37%
SG&A Expenses to Revenue	68.24%	93.83%	42.19%	45.08%	30.16%
R&D to Revenue	54.44%	67.11%	30.89%	48.67%	39.98%
Operating Expenses to Revenue	122.68%	160.93%	73.08%	93.76%	70.14%
Earnings before Interest and Taxes (EBIT)	-55	-119	-125	-175	-185
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-45	-106	-94	-147	-152
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	0.00	7.90	2.65	4.85	33.29
Price to Tangible Book Value (P/TBV)	0.00	9.23	3.41	6.47	50.37
Price to Revenue (P/Rev)	10.93	88.63	8.46	10.99	29.19
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	10.93	45.77	4.76	7.35	41.59
Enterprise Value to Revenue (EV/Rev)	17.25	79.14	6.66	10.09	29.01
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.14	0.15	0.19	1.05
Long-Term Debt to Equity	0.00	0.14	0.15	0.16	1.02
Financial Leverage	-0.49	-0.80	-0.71	-0.49	-0.32
Leverage Ratio	1.74	1.45	1.44	1.57	2.27
Compound Leverage Factor	1.73	1.52	1.53	1.61	2.32
Debt to Total Capital	0.00%	12.54%	13.26%	15.96%	51.21%
Short-Term Debt to Total Capital	0.00%	0.35%	0.37%	2.69%	1.54%
Long-Term Debt to Total Capital	0.00%	12.18%	12.89%	13.27%	49.68%
Preferred Equity to Total Capital	254.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-154.00%	87.46%	86.74%	84.04%	48.79%
Debt to EBITDA	0.00	-0.94	-1.10	-0.72	-2.65
Net Debt to EBITDA	0.00	5.56	4.03	1.49	0.52
Long-Term Debt to EBITDA	0.00	-0.92	-1.07	-0.60	-2.57
Debt to NOPAT	0.00	-1.40	-1.09	-0.85	-3.02
Net Debt to NOPAT	0.00	8.27	3.99	1.76	0.59
Long-Term Debt to NOPAT	0.00	-1.36	-1.06	-0.70	-2.93
Altman Z-Score	1.01	11.78	3.17	3.21	8.77
Noncontrolling Interest Sharing Ratio	254.00%	34.08%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	1.92	8.04	4.06	2.13	2.04
Quick Ratio	1.15	7.32	3.12	1.25	1.34
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-124	-282	-165	-101
Operating Cash Flow to CapEx	-110.49%	-279.35%	-251.20%	-193.68%	-89.62%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.19	0.11	0.21	0.25	0.41
Accounts Receivable Turnover	12.88	7.46	8.35	6.82	12.18
Inventory Turnover	1.80	1.73	2.74	1.93	2.82
Fixed Asset Turnover	0.71	1.08	2.53	1.98	2.56
Accounts Payable Turnover	13.95	18.71	24.66	9.34	7.77
Days Sales Outstanding (DSO)	28.34	48.93	43.70	53.53	29.96
Days Inventory Outstanding (DIO)	203.06	210.70	133.24	189.07	129.40
Days Payable Outstanding (DPO)	26.17	19.51	14.80	39.10	46.96
Cash Conversion Cycle (CCC)	205.23	240.12	162.15	203.50	112.39
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	55	108	295	336	304
Invested Capital Turnover	0.63	0.76	1.05	0.78	1.36
Increase / (Decrease) in Invested Capital	0.00	52	188	41	-32
Enterprise Value (EV)	606	4,925	1,406	2,468	12,655
Market Capitalization	384	5,516	1,784	2,687	12,733
Book Value per Share	($4.39)	$1.55	$1.42	$1.14	$0.77
Tangible Book Value per Share	($4.77)	$1.33	$1.10	$0.86	$0.51
Total Capital	108	799	776	660	784
Total Debt	0.00	100	103	105	401
Total Long-Term Debt	0.00	97	100	88	389
Net Debt	-53	-591	-378	-219	-78
Capital Expenditures (CapEx)	25	26	42	51	55
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-8.10	-9.68	30	26	-54
Debt-free Net Working Capital (DFNWC)	45	681	502	271	365
Net Working Capital (NWC)	45	678	499	253	353
Net Nonoperating Expense (NNE)	17	46	41	58	57
Net Nonoperating Obligations (NNO)	-53	-591	-378	-219	-78
Total Depreciation and Amortization (D&A)	9.34	12	31	28	34
Debt-free, Cash-free Net Working Capital to Revenue	-23.03%	-15.55%	14.44%	10.77%	-12.34%
Debt-free Net Working Capital to Revenue	127.12%	1,094.66%	238.04%	110.84%	83.71%
Net Working Capital to Revenue	127.12%	1,090.12%	236.67%	103.58%	80.95%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.56)	($0.29)	($0.38)	($0.38)
Adjusted Weighted Average Basic Shares Outstanding	0.00	464.78M	466.21M	481.77M	495.93M
Adjusted Diluted Earnings per Share	$0.00	($0.56)	($0.29)	($0.38)	($0.38)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	464.78M	466.21M	481.77M	495.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	($0.56)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	209.90M	477.65M	489.14M	453.55M
Normalized Net Operating Profit after Tax (NOPAT)	-38	-71	-95	-125	-133
Normalized NOPAT Margin	-109.40%	-114.78%	-44.86%	-50.92%	-30.46%
Pre Tax Income Margin	-155.11%	-200.59%	-63.01%	-73.15%	-43.42%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	-22.92%	-8.61%	-18.58%

This table displays calculated financial ratios and metrics derived from Rocket Lab's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	88.38%	34.87%	11.85%	7.30%	15.90%	68.99%	71.25%	54.90%	120.68%	32.13%	36.00%
EBITDA Growth	-924.11%	-201.19%	-31.95%	-31.24%	-38.07%	6.78%	11.54%	-38.40%	-0.53%	-41.48%	-55.27%
EBIT Growth	-6,173.28%	-129.70%	-19.77%	-20.27%	-28.81%	2.36%	6.12%	-33.70%	-3.77%	-35.72%	-46.65%
NOPAT Growth	-52.97%	-40.21%	-36.19%	-21.43%	-28.64%	6.38%	4.17%	-33.56%	-7.66%	-37.39%	-37.82%
Net Income Growth	-1,264.21%	-70.79%	-22.64%	-17.21%	-35.72%	2.97%	9.28%	-28.03%	-3.66%	-36.95%	-59.53%
EPS Growth	-133.33%	-66.67%	-25.00%	-14.29%	-25.00%	10.00%	20.00%	-25.00%	-10.00%	-33.33%	-62.50%
Operating Cash Flow Growth	13.54%	3.62%	84.15%	-9.58%	-122.83%	89.81%	-114.38%	-22.67%	94.35%	-1,995.25%	-78.78%
Free Cash Flow Firm Growth	0.00%	-1,332.10%	-69.53%	79.34%	65.25%	388.24%	598.79%	560.80%	93.97%	-241.24%	-243.02%
Invested Capital Growth	174.29%	29.00%	10.22%	14.23%	13.79%	-106.20%	-108.85%	-107.85%	-9.41%	1,961.71%	1,438.88%
Revenue Q/Q Growth	-17.91%	6.05%	13.02%	9.05%	-11.34%	54.63%	14.54%	-1.36%	26.31%	-7.42%	17.89%
EBITDA Q/Q Growth	-25.51%	-29.39%	-0.18%	19.32%	-32.03%	12.64%	4.94%	-26.23%	4.10%	-22.93%	-4.33%
EBIT Q/Q Growth	-18.76%	-18.97%	0.05%	14.83%	-27.19%	9.83%	3.90%	-21.30%	1.28%	-17.94%	-3.84%
NOPAT Q/Q Growth	-16.31%	-23.63%	1.86%	13.95%	-23.22%	10.03%	-0.45%	-19.93%	0.67%	-14.82%	-0.76%
Net Income Q/Q Growth	-7.51%	-22.60%	-0.60%	11.60%	-24.48%	12.35%	5.94%	-24.76%	-0.78%	-15.80%	-9.57%
EPS Q/Q Growth	-14.29%	-25.00%	0.00%	20.00%	-25.00%	10.00%	11.11%	-25.00%	-10.00%	-9.09%	-8.33%
Operating Cash Flow Q/Q Growth	17.62%	-33.99%	76.11%	-315.58%	-67.52%	93.87%	-402.32%	-137.81%	92.28%	-2,171.68%	57.14%
Free Cash Flow Firm Q/Q Growth	34.27%	53.66%	39.93%	-12.92%	-10.54%	484.40%	3.96%	4.31%	-101.45%	-8,910.03%	-5.27%
Invested Capital Q/Q Growth	5.19%	0.63%	1.10%	6.74%	4.78%	-105.49%	-44.23%	5.29%	1,308.69%	12.76%	3.72%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	3.54%	11.58%	23.52%	22.12%	25.82%	26.06%	25.56%	26.71%	27.81%	28.76%	32.10%
EBITDA Margin	-56.46%	-68.88%	-61.05%	-45.16%	-67.26%	-38.00%	-31.54%	-40.35%	-30.64%	-40.68%	-36.00%
Operating Margin	-71.91%	-83.83%	-72.78%	-57.43%	-79.82%	-46.44%	-40.73%	-49.52%	-38.94%	-48.29%	-41.27%
EBIT Margin	-72.11%	-80.89%	-71.53%	-55.87%	-80.15%	-46.74%	-39.22%	-48.22%	-37.69%	-48.01%	-42.29%
Profit (Net Income) Margin	-71.88%	-83.10%	-73.96%	-59.96%	-84.17%	-47.71%	-39.18%	-49.56%	-39.54%	-49.45%	-45.96%
Tax Burden Percent	97.36%	101.17%	101.69%	103.45%	102.04%	100.01%	97.98%	101.85%	101.31%	98.68%	104.63%
Interest Burden Percent	102.39%	101.54%	101.68%	103.74%	102.92%	102.07%	101.98%	100.90%	103.56%	104.39%	103.88%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-52.74%	-50.12%	-41.23%	-31.61%	-43.31%	-65.91%	-68.05%	-85.39%	-37.15%	-97.04%	-88.48%
ROIC Less NNEP Spread (ROIC-NNEP)	-50.44%	-46.95%	-37.43%	-27.71%	-37.62%	-62.56%	-65.19%	-80.99%	-26.19%	-90.49%	-82.43%
Return on Net Nonoperating Assets (RNNOA)	35.63%	28.91%	21.25%	14.75%	18.28%	46.98%	48.45%	57.20%	8.30%	58.21%	58.69%
Return on Equity (ROE)	-17.11%	-21.21%	-19.99%	-16.87%	-25.03%	-18.93%	-19.60%	-28.18%	-28.85%	-38.83%	-29.79%
Cash Return on Invested Capital (CROIC)	-140.13%	-64.73%	-48.93%	-52.24%	-52.37%	0.00%	0.00%	0.00%	-31.63%	-147.38%	-151.19%
Operating Return on Assets (OROA)	-15.45%	-17.79%	-16.69%	-13.53%	-20.31%	-12.15%	-11.81%	-16.68%	-15.47%	-18.36%	-15.55%
Return on Assets (ROA)	-15.40%	-18.27%	-17.26%	-14.52%	-21.33%	-12.40%	-11.80%	-17.14%	-16.23%	-18.91%	-16.91%
Return on Common Equity (ROCE)	-17.11%	-21.21%	-19.99%	-16.87%	-25.03%	-18.93%	-19.60%	-28.18%	-28.85%	-38.83%	-29.79%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-24.19%	-26.73%	-28.90%	0.00%	-37.84%	-38.88%	-44.86%	0.00%	-47.89%	0.00%
Net Operating Profit after Tax (NOPAT)	-26	-32	-32	-27	-34	-30	-30	-36	-36	-41	-42
NOPAT Margin	-50.34%	-58.68%	-50.95%	-40.20%	-55.87%	-32.51%	-28.51%	-34.66%	-27.26%	-33.80%	-28.89%
Net Nonoperating Expense Percent (NNEP)	-2.30%	-3.17%	-3.80%	-3.91%	-5.69%	-3.36%	-2.86%	-4.40%	-10.96%	-6.55%	-6.06%
Return On Investment Capital (ROIC_SIMPLE)	-3.36%	-4.33%	-4.42%	-3.94%	-5.08%	-5.56%	-5.86%	-7.59%	-4.60%	-4.84%	-3.78%
Cost of Revenue to Revenue	96.46%	88.42%	76.48%	77.88%	74.18%	73.94%	74.44%	73.29%	72.19%	71.24%	67.90%
SG&A Expenses to Revenue	46.43%	51.86%	46.28%	40.20%	43.15%	30.99%	28.73%	30.70%	30.30%	32.08%	27.61%
R&D to Revenue	29.01%	43.55%	50.02%	39.35%	62.49%	41.51%	37.56%	45.53%	36.45%	44.96%	45.77%
Operating Expenses to Revenue	75.45%	95.41%	96.30%	79.55%	105.64%	72.50%	66.29%	76.23%	66.75%	77.05%	73.38%
Earnings before Interest and Taxes (EBIT)	-37	-44	-44	-38	-48	-43	-42	-51	-50	-59	-61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-29	-38	-38	-31	-40	-35	-34	-42	-41	-50	-52
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.65	3.02	4.70	3.61	4.85	4.17	5.20	11.51	33.29	18.80	23.97
Price to Tangible Book Value (P/TBV)	3.41	3.92	6.15	4.76	6.47	5.85	7.39	16.82	50.37	26.67	29.29
Price to Revenue (P/Rev)	8.46	8.57	12.39	8.96	10.99	7.07	7.24	13.28	29.19	17.40	32.73
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.76	5.34	8.53	5.78	7.35	0.00	0.00	0.00	41.59	23.38	45.45
Enterprise Value to Revenue (EV/Rev)	6.66	7.05	11.05	7.83	10.09	5.31	5.77	12.06	29.01	17.21	32.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	7.77	9.16	20.37	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.15	0.16	0.17	0.18	0.19	0.13	0.13	0.14	1.05	0.98	0.61
Long-Term Debt to Equity	0.15	0.16	0.00	0.00	0.16	0.11	0.11	0.11	1.02	0.94	0.58
Financial Leverage	-0.71	-0.62	-0.57	-0.53	-0.49	-0.75	-0.74	-0.71	-0.32	-0.64	-0.71
Leverage Ratio	1.44	1.49	1.50	1.52	1.57	1.94	2.04	2.09	2.27	2.68	2.40
Compound Leverage Factor	1.47	1.52	1.52	1.58	1.62	1.98	2.08	2.11	2.35	2.79	2.49
Debt to Total Capital	13.26%	13.94%	14.59%	15.21%	15.96%	11.74%	11.89%	12.26%	51.21%	49.58%	37.70%
Short-Term Debt to Total Capital	0.37%	0.39%	14.59%	15.21%	2.69%	2.03%	2.20%	2.46%	1.54%	2.40%	1.49%
Long-Term Debt to Total Capital	12.89%	13.54%	0.00%	0.00%	13.27%	9.71%	9.69%	9.80%	49.68%	47.19%	36.21%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	86.74%	86.06%	85.41%	84.79%	84.04%	88.26%	88.11%	87.74%	48.79%	50.42%	62.30%
Debt to EBITDA	-1.10	-0.87	-0.81	-0.78	-0.72	-0.44	-0.44	-0.39	-2.65	-2.55	-2.26
Net Debt to EBITDA	4.03	2.88	2.42	1.96	1.49	3.45	3.45	2.94	0.52	0.53	1.80
Long-Term Debt to EBITDA	-1.07	-0.85	0.00	0.00	-0.60	-0.37	-0.36	-0.31	-2.57	-2.43	-2.17
Debt to NOPAT	-1.09	-1.00	-0.93	-0.90	-0.85	-0.52	-0.51	-0.45	-3.02	-2.94	-2.68
Net Debt to NOPAT	3.99	3.30	2.77	2.27	1.76	4.06	3.98	3.42	0.59	0.61	2.14
Long-Term Debt to NOPAT	-1.06	-0.97	0.00	0.00	-0.70	-0.43	-0.41	-0.36	-2.93	-2.80	-2.57
Altman Z-Score	3.46	3.22	4.29	3.01	3.66	1.53	1.75	3.64	9.15	5.51	11.29
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.06	3.22	1.83	1.67	2.13	3.12	2.82	2.58	2.04	2.08	2.67
Quick Ratio	3.12	2.28	1.20	1.02	1.25	2.25	2.05	1.73	1.34	1.34	1.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-214	-99	-59	-67	-74	285	297	309	-4.47	-403	-424
Operating Cash Flow to CapEx	-126.37%	-200.29%	-57.36%	-119.74%	-405.39%	-13.50%	-84.72%	-280.59%	-11.07%	-189.19%	-72.83%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.21	0.22	0.23	0.24	0.25	0.26	0.30	0.35	0.41	0.38	0.37
Accounts Receivable Turnover	8.35	5.38	7.09	5.87	6.82	6.90	8.64	16.19	12.18	13.21	8.98
Inventory Turnover	2.74	2.31	2.13	2.11	1.93	2.15	2.37	2.48	2.82	3.01	3.05
Fixed Asset Turnover	2.53	2.30	2.14	2.06	1.98	2.31	2.37	2.37	2.56	2.57	2.49
Accounts Payable Turnover	24.66	10.73	10.02	10.39	9.34	8.73	9.36	7.98	7.77	7.04	7.34
Days Sales Outstanding (DSO)	43.70	67.82	51.47	62.17	53.53	52.89	42.26	22.54	29.96	27.64	40.63
Days Inventory Outstanding (DIO)	133.24	158.08	171.04	173.23	189.07	169.76	154.10	147.11	129.40	121.47	119.74
Days Payable Outstanding (DPO)	14.80	34.03	36.43	35.14	39.10	41.81	39.00	45.74	46.96	51.82	49.72
Cash Conversion Cycle (CCC)	162.15	191.87	186.08	200.26	203.50	180.84	157.36	123.91	112.39	97.29	110.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	295	297	300	321	336	-18	-27	-25	304	343	356
Invested Capital Turnover	1.05	0.85	0.81	0.79	0.78	2.03	2.39	2.46	1.36	2.87	3.06
Increase / (Decrease) in Invested Capital	188	67	28	40	41	-315	-327	-346	-32	362	382
Enterprise Value (EV)	1,406	1,587	2,561	1,852	2,468	1,500	1,884	4,387	12,655	8,021	16,173
Market Capitalization	1,784	1,930	2,872	2,117	2,687	1,997	2,365	4,832	12,733	8,109	16,505
Book Value per Share	$1.42	$1.34	$1.28	$1.21	$1.14	$0.98	$0.92	$0.85	$0.77	$0.95	$1.49
Tangible Book Value per Share	$1.10	$1.03	$0.98	$0.92	$0.86	$0.70	$0.65	$0.58	$0.51	$0.67	$1.22
Total Capital	776	744	715	691	660	543	517	479	784	855	1,105
Total Debt	103	104	104	105	105	64	61	59	401	424	417
Total Long-Term Debt	100	101	0.00	0.00	88	53	50	47	389	404	400
Net Debt	-378	-343	-311	-265	-219	-497	-482	-445	-78	-88	-333
Capital Expenditures (CapEx)	15	13	11	21	10	19	15	11	22	29	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	30	42	17	19	26	12	-0.02	-4.33	-54	-31	-42
Debt-free Net Working Capital (DFNWC)	502	441	359	308	271	504	497	438	365	397	646
Net Working Capital (NWC)	499	438	254	202	253	493	485	426	353	377	630
Net Nonoperating Expense (NNE)	11	13	14	13	17	14	11	16	16	19	25
Net Nonoperating Obligations (NNO)	-378	-343	-311	-265	-219	-497	-482	-445	-78	-88	-333
Total Depreciation and Amortization (D&A)	8.10	6.60	6.51	7.24	7.73	8.11	8.16	8.25	9.33	8.98	9.08
Debt-free, Cash-free Net Working Capital to Revenue	14.44%	18.73%	7.54%	8.12%	10.77%	4.12%	0.00%	-1.19%	-12.34%	-6.69%	-8.33%
Debt-free Net Working Capital to Revenue	238.04%	195.79%	154.75%	130.14%	110.84%	178.49%	152.06%	120.41%	83.71%	85.24%	128.13%
Net Working Capital to Revenue	236.67%	194.49%	109.71%	85.67%	103.58%	174.59%	148.59%	117.17%	80.95%	80.84%	124.86%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.08)	($0.10)	($0.10)	($0.08)	($0.10)	($0.09)	($0.08)	($0.10)	($0.11)	($0.12)	($0.13)
Adjusted Weighted Average Basic Shares Outstanding	466.21M	476.20M	479.74M	484.03M	481.77M	489.99M	494.19M	497.70M	495.93M	505.61M	515.09M
Adjusted Diluted Earnings per Share	($0.08)	($0.10)	($0.10)	($0.08)	($0.10)	($0.09)	($0.08)	($0.10)	($0.11)	($0.12)	($0.13)
Adjusted Weighted Average Diluted Shares Outstanding	466.21M	476.20M	479.74M	484.03M	481.77M	489.99M	494.19M	497.70M	495.93M	505.61M	515.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	477.65M	478.66M	483.33M	485.89M	489.14M	492.78M	496.64M	499.91M	453.55M	461.43M	479.36M
Normalized Net Operating Profit after Tax (NOPAT)	-26	-32	-32	-27	-34	-30	-30	-36	-36	-41	-42
Normalized NOPAT Margin	-50.34%	-58.68%	-50.95%	-40.20%	-55.87%	-32.51%	-28.51%	-34.66%	-27.26%	-33.80%	-28.89%
Pre Tax Income Margin	-73.83%	-82.14%	-72.73%	-57.96%	-82.49%	-47.71%	-39.99%	-48.66%	-39.03%	-50.12%	-43.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-22.92%	-27.02%	-37.88%	-8.98%	-8.61%	-10.47%	-10.30%	-9.84%	-18.58%	-22.64%	-28.65%

Financials Breakdown Chart

Key Financial Trends

Rocket Lab (NASDAQ: RKLB) has shown notable revenue growth over the past four years, with quarterly operating revenue increasing from approximately $54.9 million in Q1 2023 to $144.5 million in Q2 2025. This steady top-line growth demonstrates increasing market traction and customer demand.

Despite revenue growth, the company has consistently reported net losses each quarter, with net losses deepening from around $45.6 million in Q1 2023 to $66.4 million in Q2 2025. The loss per share also reflects this trend, increasing negatively from around -$0.09 to -$0.13 per share, indicating ongoing profitability challenges.

Rocket Lab’s gross profit has improved with revenue expansion, reaching $46.4 million in Q2 2025, but high operating expenses, particularly research & development (R&D) and selling, general & administrative (SG&A) expenses, have caused operating income to remain negative. For instance, R&D expense increased to $66.1 million in Q2 2025 compared to $23.9 million in Q1 2023, showing heavy investment in product development.

Operating expenses consistently outpace gross profit, resulting in negative operating income and net income. This pattern is a typical feature of a growth-stage tech company heavily investing in innovation and scaling efforts.

On the cash flow front, Rocket Lab has experienced negative operating cash flows in most quarters, with $23.2 million outflow in Q2 2025 and deeper losses in prior quarters. Cash flows from investing activities typically show significant outflows related to capital expenditures and investment purchases, offset partially by sale and maturity of investments.

Financing activities have sharply boosted cash reserves, especially through substantial equity issuance. For example, Q2 2025 financing cash inflows were $290.5 million, primarily driven by common equity issuance of $296.4 million, strengthening the balance sheet significantly.

Rocket Lab’s cash and equivalents balance has increased markedly, from about $208 million in Q1 2023 to $564 million in Q2 2025, supported by financing inflows, providing a healthy liquidity position to fund ongoing operations and growth initiatives.

On the balance sheet, total assets rose from approximately $990 million in Q1 2023 to $1.55 billion in Q2 2025, driven by increases in cash, inventories, and property, plant, and equipment. Liabilities have also grown but at a moderate pace, resulting in total equity improvement from $478 million in Q1 2023 to $688 million in Q2 2025.

Consistent quarterly revenue growth demonstrates expanding market penetration and customer base.
Substantial increase in cash and cash equivalents, reaching $564 million by Q2 2025, providing strong liquidity.
Equity financing has successfully injected large capital inflows to support growth and operations.
Gross profit margins appear to improve with revenue scale, indicating operational leverage potential.
Continuous investment in R&D reflects commitment to technological advancement and future product development.
High and increasing R&D and SG&A expenses, while standard for growth companies, pressure profitability.
Persistent net losses and negative operating cash flow highlight the company’s current reliance on external financing.
Increasing inventories and receivables need monitoring to ensure efficient working capital management.
Consistent quarterly net losses, with no profitability in sight, may concern investors focused on earnings.
Significant cash outflows in investing activities, including capital expenditures and investments, add to cash burn risk.

In summary, Rocket Lab is executing a growth strategy with strong revenue gains and robust liquidity backed by equity financing. However, the company continues to face significant losses and cash burn driven by heavy investments in R&D and operations. Retail investors should weigh Rocket Lab’s growth potential against ongoing profitability challenges and dependence on capital markets for funding.

10/13/25 01:12 PM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Rocket Lab's Financials

When does Rocket Lab's financial year end?

According to the most recent income statement we have on file, Rocket Lab's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Rocket Lab's net income changed over the last 4 years?

Rocket Lab's net income appears to be on an upward trend, with a most recent value of -$190.18 million in 2024, rising from -$55.01 million in 2020. The previous period was -$182.57 million in 2023. Find out what analysts predict for Rocket Lab in the coming months.

What is Rocket Lab's operating income?

Rocket Lab's total operating income in 2024 was -$189.80 million, based on the following breakdown:

Total Gross Profit: $116.15 million
Total Operating Expenses: $305.95 million

How has Rocket Lab's revenue changed over the last 4 years?

Over the last 4 years, Rocket Lab's total revenue changed from $35.16 million in 2020 to $436.21 million in 2024, a change of 1,140.7%.

How much debt does Rocket Lab have?

Rocket Lab's total liabilities were at $801.89 million at the end of 2024, a 107.4% increase from 2023, and a 907.2% increase since 2020.

How much cash does Rocket Lab have?

In the past 4 years, Rocket Lab's cash and equivalents has ranged from $52.79 million in 2020 to $690.96 million in 2021, and is currently $271.04 million as of their latest financial filing in 2024.

How has Rocket Lab's book value per share changed over the last 4 years?

Over the last 4 years, Rocket Lab's book value per share changed from -4.39 in 2020 to 0.77 in 2024, a change of -117.4%.

Related Companies

This page (NASDAQ:RKLB) was last updated on 10/13/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rocket Lab (RKLB) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Rocket Lab's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rocket Lab (RKLB) Financials

Annual Income Statements for Rocket Lab

Quarterly Income Statements for Rocket Lab

Annual Cash Flow Statements for Rocket Lab

Quarterly Cash Flow Statements for Rocket Lab

Annual Balance Sheets for Rocket Lab

Quarterly Balance Sheets for Rocket Lab

Annual Metrics And Ratios for Rocket Lab

Quarterly Metrics And Ratios for Rocket Lab

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Rocket Lab's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools